‘Joshua Greenlee’
“Piezo1 Mechano-Activation Is Augmented by Resveratrol and Differs between Colorectal Cancer Cells of Primary and Metastatic Origin” published in Molecules, selected as VINSE spotlight publication
Feb. 21, 2023—Josh Greenlee is an NSF Graduate Research Fellow in the Michael King Laboratory where he has spent the last five-and-a-half years working toward his PhD. Josh’s research is focused on understanding mechanisms of metastasis and chemoresistance in colorectal cancer in order to identify weaknesses that can be exploited with targeted therapies. Josh’s recent publication in...
Dissertation Defense, Joshua Greenlee, Biomedical Engineering
Jan. 25, 2023—DISSERTATION DEFENSE Joshua Dale Greenlee, Biomedical Engineering *under the direction of Dr. Michael King “TRAIL Therapy for Exploiting Mechanisms of Drug Resistance and Metastasis in Advanced Colorectal Cancer” 02.23.23 | 9:30am | Light Hall 208 | Zoom Colorectal cancer (CRC) is the second leading cause of cancer death in the United States, accounting for over...